Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02783300
Title Dose Escalation Study of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma (NHL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

triple-receptor negative breast cancer

lung non-small cell carcinoma

ureter transitional cell carcinoma

adenoid cystic carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

estrogen-receptor positive breast cancer

Advanced Solid Tumor

non-Hodgkin lymphoma

glioblastoma

Therapies

GSK3326595

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.